discussion nursing 612

Responses to Other Students: Respond to at least 1 of your fellow classmates with at least a 250-word reply about their Primary Task Response regarding items you found to be compelling and enlightening. To help you with your discussion, please consider the following questions:

  • What did you learn from your classmate’s posting?
  • What additional questions do you have after reading the posting?
  • What clarification do you need regarding the posting?
  • What differences or similarities do you see between your posting and other classmates’ postings?

All sources should be cited using APA format. Grammar, spelling, punctuation, and format should be correct and professional. PLEASE READ THIS AND ANSWER

” Identifying the right outcomes to measure is just as important as selecting the right intervention. In evidence-based nursing practice, outcomes provide the concrete evidence needed to determine whether a change in care is actually making a difference for patients. For my PICOT question examining cryotherapy as a preventive intervention for paclitaxel-induced peripheral neuropathy (CIPN) in women with breast cancer, defining meaningful, measurable outcomes is essential to evaluating whether this nursing-led intervention warrants adoption into standard oncology practice.

The primary outcome I propose measuring is the incidence and severity of CIPN across the 12-week treatment course. This directly answers my PICOT question and captures whether cryotherapy is achieving its intended neuroprotective effect. A secondary but equally important outcome is the impact of CIPN on functional status and quality of life, since neuropathy that interferes with daily activities, fine motor tasks, or safe ambulation represents a clinically significant burden even when graded as mild on objective scales. Additional outcomes worth tracking include chemotherapy dose reductions or treatment delays attributed to neuropathy, patient tolerance of and adherence to the cryotherapy protocol, and fall-related incidents during the treatment period. Together, these outcomes create a comprehensive picture of how the intervention affects both the patients physical health and their ability to complete their cancer treatment as planned.

A mixed-method approach combining objective clinical tools with patient-reported measures would provide the most complete evaluation. The Common Terminology Criteria for Adverse Events (CTCAE) would allow nurses and providers to objectively grade neuropathy severity at each clinical encounter. The Functional Assessment of Cancer TherapyNeurotoxicity (FACT-NTX) subscale would capture the patients subjective experience of sensory symptoms and functional limitations. Melnyk and Fineout-Overholt (2023) emphasize that patient-reported outcomes are a critical component of evidence-based practice because they reflect the dimensions of care that matter most to patients themselves, which clinical grading scales alone cannot fully capture. Structured nursing assessments at each infusion visit would document symptom progression, tolerance of cryotherapy, and any safety concerns, creating a longitudinal record of the interventions effectiveness over time.

Outcome measurement should occur at multiple points rather than a single endpoint. Baseline assessment before the first paclitaxel infusion would establish each patients starting neurological status. Subsequent evaluations at weeks four, eight, and twelve would track symptom trajectory across the treatment course. A follow-up assessment at three months post-treatment completion would capture whether cryotherapy produced any lasting neuroprotective benefit during survivorship, since CIPN frequently persists beyond active treatment. Xu et al. (2023) demonstrated that patients who received extremity cooling during paclitaxel infusions showed significantly lower neuropathy burden not only during treatment but also at three months post-completion, supporting the value of extended follow-up measurement beyond the active intervention period.

If outcome data consistently demonstrate that cryotherapy reduces CIPN incidence, preserves functional status, and improves treatment tolerability, the implications for nursing practice would be far-reaching. First, it would validate nursings independent role in designing and implementing preventive interventions that meaningfully alter patient outcomes. Second, it would provide the evidence base needed to develop standardized cryotherapy protocols that could be adopted across oncology units, reducing practice variability and improving care consistency. Third, demonstrating that a low-cost, nurse-initiated intervention can prevent a serious chemotherapy complication strengthens the case for nursing involvement in supportive oncology care at an institutional and policy level. Elevating nursings contribution to CIPN prevention also reinforces the professions commitment to holistic, patient-centered care that extends beyond task completion to proactive advocacy for patient wellbeing throughout the cancer treatment journey.”

Measuring outcomes thoughtfully and systematically is what transforms a promising intervention into an evidence-based practice change. By tracking CIPN severity, functional impact, treatment continuity, and patient-reported experience at multiple time points, nurses can build the kind of rigorous, practice-changing evidence that benefits both individual patients and the broader nursing profession.

Melnyk, B. M., & Fineout-Overholt, E. (2023). Evidence-based practice in nursing and healthcare: A guide to best practice (5th ed.). Wolters Kluwer.

Tandon, M., Yacur, M., Brenin, C., & Dillon, P. (2024). Cryotherapy for prevention of chemotherapy-induced peripheral neuropathy in breast cancer. Critical Reviews in Oncology/Hematology, 194, Article 104244.

Xu, M., Wang, F., Zhu, X., & Hao, Z. (2023). Efficacy of cryotherapy on chemotherapy-induced peripheral neuropathy in patients with breast cancer: A propensity score-matched study. Annals of Medicine and Surgery, 85(6), 26952703.

WRITE MY PAPER


Comments

Leave a Reply